Afuco™ Anti-Human Angiostatin ADCC Recombinant Antibody, ADCC Enhanced (CAT#: AFC-036CL)
Anti-Angiostatin ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. Anti-angiostatin receptor monoclonal antibody is a chimeric antibody, while maintaining its anti-angiostatin receptor activity, making it more suitable for in vivo applications. The monoclonal antibody has a natural tumor cell membrane surface antigen-binding activity and can inhibit tumor cell surface ATP synthesis, anti-tumor therapy has important significance.
Specific Inquiry
Specifications
- Host Species
- Chimeric (human/mouse)
- Derivation
- Chimeric (human/mouse)
- Type
- ADCC enhanced antibody
- Species Reactivity
- Human
- Related Disease
- Cancer
Product Property
- Purity
- >90% assessed by SDS-PAGE
- Storage
- 4°C or -20°C, avoid repeated freezing and thawing.
Target
- Alternative Names
- Angiostatin
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-036CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.